Multifunctional Natural Products in Disease Modulation: A Systems Perspective on Cancer and Cardiovascular Therapies

Background: Natural products have long served as a vital source of pharmacologically active compounds, offering unique structural diversity, evolutionary optimization, and biological specificity. In this review, we examine the multifaceted roles of natural products in the prevention and treatment of cancer and cardiovascular disease (CVD), two major global health burdens. Natural products exhibit multitargeted mechanisms of action, modulating pathways related to proliferation, apoptosis, angiogenesis, inflammation, oxidative stress, and immune regulation. Classic cytotoxics like paclitaxel and vinca alkaloids continue to serve as chemotherapeutic mainstays, while non-cytotoxic phytochemicals such as curcumin, resveratrol, and EGCG influence epigenetic regulation and tumor microenvironment remodeling. In cardiovascular contexts, flavonoids and alkaloids demonstrate potent antioxidant, anti-inflammatory, and metabolic benefits through the activation of signaling pathways including eNOS, AMPK, and Nrf2. Despite promising pharmacological profiles, many natural products face clinical translation challenges due to poor solubility, low bioavailability, and regulatory limitations. Emerging strategies—such as nanoformulations, bioenhancers, synthetic biology, systems pharmacology, and AI-guided drug development—offer promising solutions to these barriers. Bridging traditional knowledge with modern scientific advances may accelerate the integration of natural products into precision medicine, establishing them as cornerstone agents in the future of therapeutic innovation.